Clinical Trial Update: An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH

View source ↗

Summary

An open-label, multicenter study is evaluating the safety and tolerability of dry powder inhaled treprostinil in patients with pulmonary hypertension, including…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Interstitial Lung Disease
• Pulmonary Hypertension

Drugs mentioned

• Treprostinil (dry powder inhalation) (treprostinil)

Snippet

Sponsor: Liquidia Technologies, Inc. | Conditions: Pulmonary Hypertension, Interstitial Lung Disease | Status: ACTIVE_NOT_RECRUITING